Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRONMAN: IV Iron in Heart Failure and Iron Deficiency
NCT02642562Phase 4Completed
- Sponsor
- University of Glasgow
- Start
- Aug 2016
- Primary completion
- Aug 2022
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ferric derisomaltose in chronic heart failure (CHF) and iron deficiency anemia (IDA), sponsored by University of Glasgow. Started Aug 2016; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
chronic heart failure (CHF)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02642562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02642562.